Advisory Research Inc Novartis Ag Transaction History

Advisory Research Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2018 Aug 14, 2018	SELL	$64.91 - $73.36 $18 Million - $20.4 Million	-278,051 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$70.39 - $84.15 $876,989 - $1.05 Million	12,459 Added 4.69%	278,051 $22.5 Million
Q4 2017 Feb 08, 2018	SELL	$72.33 - $77.64 $157,028 - $168,556	-2,171 Reduced 0.81%	265,592 $22.3 Million
Q3 2017 Nov 14, 2017	BUY	$74.14 - $77.27 $19.9 Million - $20.7 Million	267,763	267,763 $23 Million

1,472

134M

1.31M

1.56M

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $230B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

Get notified when there are updates to the investment portfolio of Advisory Research Inc, based on Form 13F filings with the SEC.

Stay updated on Advisory Research Inc with notifications on news.